p53 expression as a prognostic marker in inflammatory breast cancer.
Gonzalez-Angulo
Ana M
AM
Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Sneige
Nour
N
Buzdar
Aman U
AU
Valero
Vicente
V
Kau
Shu-Wan
SW
Broglio
Kristine
K
Yamamura
Yuko
Y
Hortobagyi
Gabriel N
GN
Cristofanilli
Massimo
M
D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D002467:Cell Nucleus / Q000378:metabolism; D018572:Disease-Free Survival; D005260:Female; D016158:Genes, p53; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000494:pharmacology; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*
D016159:Tumor Suppressor Protein p53; D017239:Paclitaxel